App-Quantinova.ai

IMPACT OF PROTON PUMP INHIBITOR ON ONE-YEAR CLINICAL OUTCOMES IN PATIENTS UNDERWENT PERCUTANEOUS CORONARY INTERVENTION ACCORDING TO DUAL VERSUS TRIPLE ANTIPLATELET AGENTS

Sang-Ho Park - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

aspirin + clopidogrel

STENT FRACTURE DETECTION USING INTRACORONARY OPTICAL COHERENCE TOMOGRAPHY: A PROOF OF CONCEPT AND COMPARISON OF THREE DIMENSIONAL IMAGING MODALITIES

Sulaiman Aziz Rathore - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

DIFFERENTIAL CHANGES IN PLAQUE BEHIND THE STENT AFTER BARE-METAL AND DRUG-ELUTING STENT IMPLANTATION IN HUMANS: IMPLICATIONS FOR LATE STENT FAILURE?

Ioannis Andreou - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Paclitaxel

RISK OF STENT THROMBOSIS IN CARDIAC ARREST PATIENTS WITH ST- ELEVATION MYOCARDIAL INFARCTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION AND THERAPEUTIC HYPOTHERMIA: INTERNATIONAL CARDIAC ARREST REGISTRY

Nainesh Patel - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

LATE DIFFERENCE OF CLINICAL OUTCOME BETWEEN ZOTAROLIMUS VERSUS EVEROLIMUS ELUTING CORONARY STENTS IN AN ISOLATED PROXIMAL LEFT ANTERIOR DESCENDING ARTERY LESION

Nikolaos Anousakis-Vlachochristou - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

INCIDENCE AND CLINICAL IMPACT OF LONGITUDINAL STENT DEFORMATION AFTER THE PROMUS ELEMENT PLATINUM CHROMIUM-EVEROLIMUS ELUTING STENT IMPLANTATION

Takashi Hiromasa - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Promus Element

ZOTAROLIMUS ELUTING STENT VERSUS EVEROLIMUS ELUTING STENT IN PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Alok Saurav - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

TWO-YEAR CLINICAL OUTCOMES OF THE NOBORI BIOLIMUS-ELUTING STENT AND XIENCE EVEROLIMUS-ELUTING STENT IN PATIENTS TREATED WITH IN-STENT RESTENOSIS

Takashi Hiromasa - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

LONG-TERM CLINICAL OUTCOME OF ROTATIONAL ATHERECTOMY FOLLOWED BY EVEROLIMUS-ELUTING STENT IMPLANTATION FOR SEVERELY CALCIFIED DE NOVO CORONARY LESIONS: RESULTS FROM TOKYO-MD PCI STUDY

Yoichi Otaki - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

THREE-YEAR CLINICAL OUTCOME COMPARISON BETWEEN EVEROLIMUS- VERSUS ZOTAROLIMUS-ELUTING STENTS IN ALL-COMERS AND DIABETICS

Shaopeng Xu - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

IMPACT OF THE ABSORB BIORESORBABLE VASCULAR SCAFFOLD SURFACE AREA ON ON-TREATMENT PLATELET REACTIVITY

Lisa Gross - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

A SYSTEMATIC REVIEW OF PERCUTANEOUS CLOSURE OF RUPTURED SINUS OF VALSALVA ANEURYSM IN ADULTS

Abhishek Matta - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

A DIFFERENT DES SHOULD BE IMPLANTED FOR DES-ISR

Takayuki Yabe - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

SAFE PERIOD OF ANTICOAGULATION WITHDRAWAL IN PATIENTS WITH MECHANICAL HEART VALVE(S)

Rafael Cavalcanti - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Warfarin

THE RISK OF THROMBOEMBOLIC COMPLICATIONS WITHOUT ANTICOAGULATION AFTER SURGICAL AORTIC VALVE REPLACEMENT WITH A BIOPROSTHESIS

Peter B. Berger - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Warfarin

VORAPAXAR AND ACUTE LIMB ISCHEMIA: INSIGHTS FROM THE THROMBIN RECEPTOR ANTAGONIST IN SECONDARY PREVENTION OF ATHEROTHROMBOTIC ISCHEMIC EVENTS-TIMI 50 TRIAL

Antonio Gutierrez - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Vorapaxar

PROBABILITY OF DEVELOPING PROXIMAL DEEP VEIN THROMBOSIS AND/OR PULMONARY EMBOLISM WITHIN ONE YEAR AFTER AN ISOLATED EPISODE OF DISTAL DEEP VEIN THROMBOSIS OF THE LOWER EXTREMITIES

Krishna Patel - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

FATAL BLEEDING, CASE-FATALITY RATE OF MAJOR BLEEDING AND ALL-CAUSE MORTALITY IN PATIENTS TAKING TARGET-SPECIFIC ORAL ANTICOAGULANT, A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Chatree Chai-Adisaksopha - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Methadone hydrochloride

THE EFFECT OF STATINS ON THE RISK OF VENOUS THROMBOEMBOLISM: A SYSTEMATIC REVIEW AND META-ANALYSIS

Sascha Ostberg - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Albyl-E

IMPACT OF ANNUAL INSTITUTIONAL VOLUMES ON COMPARATIVE SAFETY OUTCOMES OF CATHETER DIRECTED THROMBOLYSIS VERSUS ANTICOAGULATION THERAPY IN THE TREATMENT OF LOWER EXTREMITY PROXIMAL DEEP VEIN THROMBOSIS

Harish Jarrett - American College of Cardiology (ACC) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts